☆ 4.7 Letter

Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)

ANNALS OF SURGICAL ONCOLOGY (2021)

Get Full Text
Add to Collection

Journal

ANNALS OF SURGICAL ONCOLOGY
Volume 28, Issue 8, Pages 4095-4097

Publisher

SPRINGER
DOI: 10.1245/s10434-021-10112-z

Keywords

-

Categories

Oncology Surgery

Funding

  1. BioNtech AG
  2. Boehringer Ingelheim
  3. Bristol Myers Squibb
  4. EMD Serono
  5. Immatics
  6. Pfizer

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.